Page contentsPage contents Key facts Decision Key facts Active substance ciclosporin Therapeutic area Ophthalmology Decision number P/0140/2023 PIP number EMEA-003366-PIP01-22 Pharmaceutical form(s) Eye drops, solution Condition(s) / indication(s) Treatment of dry eye disease Route(s) of administration Ocular use Contact for public enquiries Novaliq GmbHE-mail: Info@novaliq.com Tel.: +49 6221502590 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 14/04/2023 Compliance check done No Decision P/0140/2023 : EMA decision of 14 April 2023 on the granting of a product specific waiver for ciclosporin (EMEA-003366-PIP01-22)Reference Number: EMA/127645/2023 English (EN) (226.47 KB - PDF)First published: 22/07/2024 View Share this page